Disclaimer: Cannabis remains illegal for recreational use in Nigeria under the Indian Hemp Act (1966) and the NDLEA Act (2004). The Sanu Attorneys does not assist clients with any activity currently prohibited by Nigerian law, including cultivation, sale, or possession of cannabis. All services are provided strictly within the confines of existing legal frameworks and international treaty obligations. This page does not constitute legal advice.
The Landscape: Where Nigeria Stands
Indian Hemp Act (1966)
Prohibits cultivation, sale, possession. Penalties: 4 years to life imprisonment.
NDLEA Act (2004)
Empowers enforcement. Cannabis seizures exceed 15 million kg in five years - 75% of all illicit drugs intercepted.
UN Single Convention (1961)
Binds Nigeria to restrict cannabis to medical and scientific purposes.
The Narrow Corridor for Medical Cannabis & Industrial Hemp
A technical pathway exists for medical cannabis (cannabis-derived medicines) under NAFDAC's pharmaceutical registration, with an additional NDLEA no-objection layer. This "narrow corridor" is rarely navigated and demands sophisticated legal expertise.
Industrial hemp (cannabis sativa with ≤0.3% THC) may follow a separate regulatory trajectory. While no standalone framework yet exists, we monitor developments in agricultural and industrial policy.
Important distinction: The Indian Hemp Act's theoretical allowance for "medicinal preparations" is not a practical pathway for commercial products. In practice, cannabis-derived medicines must follow NAFDAC's standard pharmaceutical registration process, with an additional NDLEA no-objection layer. We advise on this narrow, rarely used route.
Reform Is Imminent – As of 2026 the following developments are confirmed:
Sept 2025
National Assembly confirms active drafting of medical/industrial cannabis legislation.
Jan 2026
NDLEA launches Alternative Livelihoods Scheme for cannabis farmers in Ondo State.
May 2025
Amended NDLEA Act passed, awaiting Presidential assent.
Oct 2025
Nigerian Academy of Science convenes stakeholder dialogue on medical cannabis oil.
Market Opportunity Snapshot
●
Industry analysts project significant growth in the African medical cannabis market over the next decade. Nigeria – with the continent's largest economy – could become a major player.
●
Nigeria's potential: largest economy, extensive arable land, and an existing farming ecosystem that could transition to regulated production.
●
Pharma vs. Industrial – Medical cannabis follows pharmaceutical regulation; industrial hemp (low THC) may be regulated as an agricultural commodity. We advise on both.
●
Export opportunity: Lesotho, Zimbabwe, and South Africa have already licensed exports to Europe and Israel. Nigeria can follow.
The question is not whether Nigeria will regulate cannabis. It is whether you will be ready.
What You Should Be Doing Now
We do not advise current illegal activity. But forward-looking organisations can take lawful steps today:
Pre-licensing structuring
Entity formation, governance, and compliance frameworks that will be ready when regulations are published.
Regulatory intelligence gathering
Monitoring NDLEA, NAFDAC, and National Assembly activities. We do this daily on your behalf.
Partnership positioning
Identifying local farming cooperatives, extraction technology providers, and offtake agreements (all contingent on legalisation).
Compliance readiness
Auditing potential supply chains, quality control systems, and pharmacovigilance protocols to meet future Nigerian and international standards.
Why The Sanu Attorneys?
Health Law Meets Cannabis Regulation
Most firms approach cannabis through criminal defence or corporate commercial work. Neither is sufficient. Cannabis is fundamentally a pharmaceutical product – requiring expertise in drug scheduling, clinical trials, physician liability, and patient access.
Global Perspective, Local Intelligence
We combine Nigerian administrative and criminal law expertise with comparative regulatory knowledge from Canada, Germany, South Africa, Zimbabwe, and Lesotho.
Our Services
Regulatory & Compliance Advisory
Regulatory roadmapping, NDLEA & NAFDAC liaison, compliance audits, policy advocacy, medical cannabis import authorization advisory.
Corporate & Commercial
Entity formation, investment structuring, IP protection, contract negotiation, real estate advisory.
Criminal Defence & Litigation
NDLEA defence, asset forfeiture challenges, constitutional litigation, international extradition defence.
Health Law & Patient Advocacy
Patient access program design (future markets), clinical trial support, pharmacovigilance, compassionate use advisory.
International & Cross-Border
Market entry strategy, export/import compliance, diaspora investment structuring, global regulatory intelligence.
Who We Serve
| Client |
Our Commitment |
| Local Entrepreneurs & Farmers |
Pre-compliance structuring and future licensing positioning. |
| International Investors |
Regulatory due diligence and responsible market entry strategy. |
| Healthcare Institutions |
Navigating the medical exception safely. |
| Patient Advocates |
Evidence-based reform and defence of medical users. |
| Policymakers & Regulators |
Technical assistance for compliant, health-centered reform. |
Frequently Asked Question
Do you help clients grow or sell cannabis in Nigeria today?
No. We advise strictly on regulatory compliance, future positioning, and the narrow existing pathways for medicinal preparations and authorized import/export. We do not assist with any activity currently prohibited by the Indian Hemp Act or NDLEA Act.
Our Commitment
Reform must be evidence-based, equitable, health-centered, legally sound, and grounded in human dignity.